EATON VANCE MANAGEMENT – Alnylam Pharmaceuticals, Inc. Transaction History
EATON VANCE MANAGEMENT portfolio value:
$61.50M
portfolio value
EATON VANCE MANAGEMENT quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.18% | 537 shares | 16.76M | $200.16 | 307.28K |
| Q2 2022 | share | Increase | +0.17% | 523 shares | -5.26M | $145.85 | 306.75K |
| Q1 2022 | share | Increase | +606.65% | 262.89K shares | 42.65M | $163.29 | 306.22K |
| Q4 2021 | share | Decrease | -1.53% | -674 shares | -983K | $171.03 | 43.33K |
| Q3 2021 | share | Increase | +6.07% | 2.51K shares | 1.26M | $188.81 | 44.00K |
| Q2 2021 | share | Decrease | -9.54% | -4.37K shares | 557K | $169.52 | 41.49K |
| Q1 2021 | share | Decrease | -69.35% | -103.79K shares | -12.97M | $141.19 | 45.86K |
| Q4 2020 | share | Decrease | -30.06% | -64.31K shares | -11.70M | $129.97 | 149.66K |
| Q3 2020 | share | Decrease | -3.05% | -6.74K shares | -1.53M | $145.6 | 213.98K |
| Q2 2020 | share | Increase | +0.05% | 112 shares | 8.67M | $148.11 | 220.72K |
| Q1 2020 | share | Increase | +0.02% | 34 shares | -1.39M | $108.85 | 220.61K |
| Q4 2019 | share | Decrease | -0.01% | -24 shares | 7.66M | $115.17 | 220.58K |
| Q3 2019 | share | 0.00% | 0 shares | 1.73M | $80.42 | 220.60K | |
| Q2 2019 | share | Decrease | -37.28% | -131.12K shares | -16.86M | $72.56 | 220.60K |
| Q1 2019 | share | Increase | +830.73% | 313.94K shares | 30.11M | $93.45 | 351.73K |
| Q4 2018 | share | 0.00% | 0 shares | -552K | $72.91 | 37.79K | |
| Q3 2018 | share | 0.00% | 0 shares | -415K | $87.52 | 37.79K | |
| Q2 2018 | share | Increase | +2.65% | 975 shares | -663K | $98.49 | 37.79K |
| Q1 2018 | share | Decrease | -0.14% | -50 shares | -299K | $119.1 | 36.81K |
| Q4 2017 | share | Increase | +15.69% | 5K shares | 940K | $127.05 | 36.86K |
| Q3 2017 | share | Decrease | -0.26% | -83 shares | 1.19M | $117.49 | 31.86K |
| Q2 2017 | share | 0.00% | 0 shares | 911K | $79.76 | 31.94K | |
| Q1 2017 | share | Decrease | -0.31% | -100 shares | 437K | $51.25 | 31.94K |
| Q4 2016 | share | Increase | +0.16% | 50 shares | -969K | $37.44 | 32.04K |
| Q3 2016 | share | 0.00% | 0 shares | 393K | $67.78 | 31.99K | |
| Q2 2016 | share | Decrease | -0.31% | -100 shares | -239K | $55.49 | 31.99K |
| Q1 2016 | share | Increase | +0.63% | 200 shares | -988K | $62.77 | 32.09K |